Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMU...DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 1064MG/3.9ML (272.82MG/ML)
USFDA APPLICATION NUMBER - 207533
DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMU...DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 441MG/1.6ML (275.63MG/ML)
USFDA APPLICATION NUMBER - 207533
DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMU...DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 662MG/2.4ML (275.83MG/ML)
USFDA APPLICATION NUMBER - 207533
DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMU...DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 882MG/3.2ML (275.63MG/ML)
USFDA APPLICATION NUMBER - 207533
DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMU...DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 675MG/2.4ML (281.25MG/ML)
USFDA APPLICATION NUMBER - 209830
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Emulsifying Agents
Topical
Surfactant & Foaming Agents
Thickeners and Stabilizers
Film Formers & Plasticizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ANALYTICAL
ABOUT THIS PAGE
A Aripiprazole Lauroxil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aripiprazole Lauroxil, including repackagers and relabelers. The FDA regulates Aripiprazole Lauroxil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aripiprazole Lauroxil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aripiprazole Lauroxil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aripiprazole Lauroxil supplier is an individual or a company that provides Aripiprazole Lauroxil active pharmaceutical ingredient (API) or Aripiprazole Lauroxil finished formulations upon request. The Aripiprazole Lauroxil suppliers may include Aripiprazole Lauroxil API manufacturers, exporters, distributors and traders.
click here to find a list of Aripiprazole Lauroxil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aripiprazole Lauroxil DMF (Drug Master File) is a document detailing the whole manufacturing process of Aripiprazole Lauroxil active pharmaceutical ingredient (API) in detail. Different forms of Aripiprazole Lauroxil DMFs exist exist since differing nations have different regulations, such as Aripiprazole Lauroxil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aripiprazole Lauroxil DMF submitted to regulatory agencies in the US is known as a USDMF. Aripiprazole Lauroxil USDMF includes data on Aripiprazole Lauroxil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aripiprazole Lauroxil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aripiprazole Lauroxil suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aripiprazole Lauroxil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aripiprazole Lauroxil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aripiprazole Lauroxil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aripiprazole Lauroxil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aripiprazole Lauroxil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aripiprazole Lauroxil suppliers with NDC on PharmaCompass.
Aripiprazole Lauroxil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aripiprazole Lauroxil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aripiprazole Lauroxil GMP manufacturer or Aripiprazole Lauroxil GMP API supplier for your needs.
A Aripiprazole Lauroxil CoA (Certificate of Analysis) is a formal document that attests to Aripiprazole Lauroxil's compliance with Aripiprazole Lauroxil specifications and serves as a tool for batch-level quality control.
Aripiprazole Lauroxil CoA mostly includes findings from lab analyses of a specific batch. For each Aripiprazole Lauroxil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aripiprazole Lauroxil may be tested according to a variety of international standards, such as European Pharmacopoeia (Aripiprazole Lauroxil EP), Aripiprazole Lauroxil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aripiprazole Lauroxil USP).
LOOKING FOR A SUPPLIER?
